Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2010-4-15
pubmed:abstractText
We previously reported increased binding of (+)[11C]DTBZ (dihydrotetrabenazine), the vesicular monoamine transporter (VMAT2) positron emission tomography (PET) radioligand, in striatum of some methamphetamine users. This finding might be explained by stimulant-induced vesicular DA depletion resulting in decreased DA (+)[11C]DTBZ competition at VMAT2. In a prospective PET study, we now find that administration of an acute oral dose of amphetamine (0.4 mg/kg) to humans does not cause increased striatal (+)[11C]DTBZ binding but a slight 5% decrease. Our data suggest that a low amphetamine dose is unlikely to cause sufficient DA depletion to detect increased (+)[11C]DTBZ binding and that a higher dose might be required.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1098-2396
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
64
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
417-20
pubmed:meshHeading
pubmed-meshheading:20169578-Administration, Oral, pubmed-meshheading:20169578-Adult, pubmed-meshheading:20169578-Amphetamine, pubmed-meshheading:20169578-Amphetamine-Related Disorders, pubmed-meshheading:20169578-Binding, Competitive, pubmed-meshheading:20169578-Central Nervous System Stimulants, pubmed-meshheading:20169578-Corpus Striatum, pubmed-meshheading:20169578-Dopamine, pubmed-meshheading:20169578-Dose-Response Relationship, Drug, pubmed-meshheading:20169578-Female, pubmed-meshheading:20169578-Humans, pubmed-meshheading:20169578-Male, pubmed-meshheading:20169578-Positron-Emission Tomography, pubmed-meshheading:20169578-Prospective Studies, pubmed-meshheading:20169578-Tetrabenazine, pubmed-meshheading:20169578-Vesicular Monoamine Transport Proteins, pubmed-meshheading:20169578-Young Adult
pubmed:year
2010
pubmed:articleTitle
Influence of a low dose of amphetamine on vesicular monoamine transporter binding: a PET (+)[11C]DTBZ study in humans.
pubmed:affiliation
Human Neurochemical Pathology Laboratory, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada. isabelle_boileau@camh.net
pubmed:publicationType
Journal Article